Dana Sullivan

Vice President, Therapy Development @Conformal Medical

Nashua, NH, US

Primary responsibility for the driving enrollment in the CONFORM Pivotal trial, a 1600 patient randomized trial to gain approval for a next generation Left Atrial Appendage Occlusion (LAAO) device. Manage a Therapy Development team that has primary responsibility for site Primary Investigator (PI) engagement, and interaction. Site identification for potential CONFORM sites and interacting with Key Opinion Leaders (KOL) and Principal Investigators (PI) and research teams.

Framingham State University

Bachelor's degree